About Vesocclude
Vesocclude is a Healthcare company based in Raleigh (United States) founded in 2005, and was acquired by Symmetry Surgical in August 2015. Lligation clips and appliers for vascular closure. Vesocclude has raised $1.52 million across 1 funding round from investors including Symmetry Surgical. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Saranas and Aziyo Biologics; 3 of its 3 listed competitors have raised funding.
Company details
Vesocclude is a medical device company specializing in advanced development of ligation products including superior manual ligating clips and loading devices for multiple medical specialties. Its ligation clips and appliers are used in surgical procedures to close tubal anatomic structures such as blood vessels or ducts. The portfolio consists of several sizes of titanium clips used to close the structures, which come loaded in a patented push and click cartridge system. Acquired by Symmetry Surgical in Aug 2015.
- Headquarters Raleigh, United States
- Stage Acquired
- SectorsHealthcare
- Website vesocclude.com
- Social LinkedIn
- Acquired by Symmetry Surgical (Aug 2015)
- Total Equity Funding$1.52M (USD)
in 1 rounds
- Latest Funding Round$1.52M (USD), Seed
Oct 2011
- Investors
- Acquired bySymmetry Surgical
(Aug 2015)
Funding Insights of Vesocclude
Vesocclude has successfully raised a total of $1.52M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.52 million completed in October 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.52M
- Total Rounds 1
- Last Round Seed — $1.52M
- First Round $1.52M
(Oct 2011)
All 1 funding rounds of Vesocclude with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2011 | $1.52M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Vesocclude
Vesocclude has secured backing from 1 investor. Prominent investors backing the company include Symmetry Surgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Surgical instruments, sterilization solutions and electrosurgical products | 1976 | symmetrysurgical.com | Nashville, United States |
Investor details for Vesocclude
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vesocclude
3 dated milestones of Vesocclude across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Vesocclude is founded.
- Funding First funding round of $1.5M.
- Exit Acquired by Symmetry Surgical.
Competitors of Vesocclude
Vesocclude has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Saranas and Aziyo Biologics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| saranas.com | 2011 | Houston, United States | $29.46M | A device is developed for detecting internal bleeding during catheterization. | ||
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. |
Detailed competitors of Vesocclude
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Vesocclude (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vesocclude
Vesocclude was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Vesocclude is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Vesocclude is a funded company, having raised a total of $1.52M across 1 funding round to date. The company's 1st funding round was a Seed of $1.52M, raised on Oct 2011.
Vesocclude is a medical device company specializing in advanced development of ligation products including superior manual ligating clips and loading devices for multiple medical specialties. Its ligation clips and appliers are used in surgical procedures to close tubal anatomic structures such as blood vessels or ducts. The portfolio consists of several sizes of titanium clips used to close the structures, which come loaded in a patented push and click cartridge system. Acquired by Symmetry Surgical in Aug 2015.
Vesocclude's top competitors include Cardival Medical, Aziyo Biologics and Saranas.
Vesocclude has 1 investor. Key investors include Symmetry Surgical.
Yes. Vesocclude was acquired by Symmetry Surgical in August 2015.